EUVIMEDEUVIMED entdecken
Crossref

From Separation to Safety Prediction: Validated RP‐HPLC Method for Simultaneous Estimation of Sitagliptin and Lobeglitazone, LC‐MS/MS Identification of Degradant Products, and In Silico Safety Profiling

Rutvi Patel, Akshita Moradia, Viraj Prajapati, Gaurav Panchal, Kushal Shah, Kashyap Thummar iD

Biomedical Chromatography · 2026

DOI: 10.1002/bmc.70301 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biomedical Chromatography, 2026. Verfasst von Rutvi Patel und 5 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, Gujarat Technological University, Gandhinagar, Gujarat, India. Hauptthemen laut MEDLINE: Tandem Mass Spectrometry, Sitagliptin Phosphate, Chromatography, Reverse-Phase, Thiazolidinediones. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 23 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Diabetes mellitus is a global health burden, necessitating effective combination therapies. The fixed‐dose formulation of sitagliptin phosphate (SGP, 100 mg) and lobeglitazone sulfate (LGS, 0.5 mg) offers synergistic benefits by enhancing insulin sensitivity and glucose‐dependent insulin secretion. However, simultaneous quantification remains challenging due to their dosage disparity and the narrow therapeutic index of LGS. This study reports a validated, stability‐indicating RP‐HPLC method for concurrent estimation of SGP and LGS in a synthetic mixture. Separation was achieved on a Pursuit 5 Diphenyl column (150 × 4.6 mm, 5 μm) using a gradient of 0.1% formic acid and acetonitrile at 1.0 mL/min, with PDA detection at 254 nm. The method complied with ICH Q2(R2) guidelines, showing specificity, linearity, accuracy, precision, and robustness. Forced degradation studies revealed marked instability of SGP under acidic and alkaline conditions, whereas LGS remained stable. LC‐MS/MS analysis identified a major degradation product at m / z 234, and probable fragmentation pathways were proposed. In silico ADMET and toxicity profiling predicted high gastrointestinal absorption for all degradation products, with PI‐1 and PI‐2 flagged for carcinogenicity and all except PI‐3 showing nephrotoxicity. This integrated analytical–computational approach provides a reliable tool for quality control and safety assessment of this antidiabetic formulation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Tandem Mass SpectrometrySitagliptin PhosphateChromatography, Reverse-PhaseThiazolidinedionesPyrimidinesHypoglycemic AgentsChromatography, High Pressure LiquidReproducibility of ResultsLinear ModelsLimit of DetectionComputer SimulationDrug StabilitySensitivity and SpecificityLiquid Chromatography-Mass Spectrometry

Stichwörter der Autor:innen

LC‐MS/MSRP‐HPLCdiabetes mellitusin silicolobeglitazone sulfatesitagliptin phosphate

Substanzen

Sitagliptin PhosphateThiazolidinedioneslobeglitazonePyrimidinesHypoglycemic Agents

Autor:innen und Institutionen

  • School of Pharmacy, Gujarat Technological University, Gandhinagar, Gujarat, India.

ORCID-Profile: Kashyap Thummar

Zitieren

APA

Patel, R., Moradia, A., Prajapati, V., Panchal, G., Shah, K., & Thummar, K. (2026). From Separation to Safety Prediction: Validated RP‐HPLC Method for Simultaneous Estimation of Sitagliptin and Lobeglitazone, LC‐MS/MS Identification of Degradant Products, and In Silico Safety Profiling. Biomedical Chromatography. https://doi.org/10.1002/bmc.70301

Vancouver

Patel R, Moradia A, Prajapati V, Panchal G, Shah K, Thummar K. From Separation to Safety Prediction: Validated RP‐HPLC Method for Simultaneous Estimation of Sitagliptin and Lobeglitazone, LC‐MS/MS Identification of Degradant Products, and In Silico Safety Profiling. Biomedical Chromatography. 2026. doi:10.1002/bmc.70301

BibTeX
@article{Patel2026,
  author = {Patel, Rutvi and Moradia, Akshita and Prajapati, Viraj and Panchal, Gaurav and Shah, Kushal and Thummar, Kashyap},
  title = {From Separation to Safety Prediction: Validated RP‐HPLC Method for Simultaneous Estimation of Sitagliptin and Lobeglitazone, LC‐MS/MS Identification of Degradant Products, and In Silico Safety Profiling},
  journal = {Biomedical Chromatography},
  year = {2026},
  doi = {10.1002/bmc.70301}
}
Kostenlos starten →